Integrated geneman-mouller structure capable of releasing drug

Abstract

The utility model relates to the field of gynecological appliances, in particular to a comprehensive Genimann-Luolele structure capable of releasing medicine by using a copper ring. The upper part of the fixing line can be nailed and hung in the uterine cavity; a plurality of copper rings are arranged on the fixing line in a penetrating manner, an upper bracket is arranged above a copper ring body, and a lower bracket is arranged below the copper ring body; the fixing line penetrates through the penetrating holes in the upper support and the lower support. The lower support can support medicine arranged in the copper ring, and the medicine is levonorgestrel. After the Munule and the Gini ring are combined into one and refitted, the Munule is fixed in the uterine superficial muscle layer through the Gini knot, the problems that the Munule moves downwards and falls off are perfectly solved, the treatment effect is achieved, and meanwhile the efficient and long-acting contraception effect is achieved for women with contraception requirements.

Description

Technical Field

[0001] The utility model relates to the field of gynecological appliances, in particular to a comprehensive Giniman Yuele structure capable of releasing medicines through a copper ring. Background Art

[0002] Mirena, commonly known as the levonorgestrel-releasing intrauterine contraceptive system, can effectively prevent pregnancy. On the other hand, it also provides additional benefits for patients with adenomyosis, such as relieving dysmenorrhea, reducing menstrual volume, and correcting anemia. However, the uterine cavity of such patients is often enlarged and deformed. In addition, because Mirena is made of a very light material and does not come in large or small sizes, it is very easy to move downward or even fall off in a short period of time after placement.

[0003] The Gini Ring is an intrauterine device designed specifically for people with a large uterine cavity, a loose cervix, and intrauterine devices that are prone to falling out after placement. However, it only has a contraceptive effect and has no therapeutic effect on patients with adenomyosis.

[0004] Adenomyosis is a common and difficult gynecological disease. It most commonly occurs in multiparous women aged 30 to 50, but can also occur in younger nulliparous women. Approximately 15% of patients have coexisting endometriosis, and approximately 50% have coexisting uterine fibroids. Clinically, it often presents with heavy menstruation accompanied by dysmenorrhea. Color Doppler ultrasound often reveals an enlarged uterus, with varying degrees of deformation of the uterine cavity. Treatment for this disease can include medication and surgery, but a complete cure is difficult and requires individualized selection based on the patient's age, symptoms, and fertility needs. Clinical guidelines recommend Mirena as the preferred treatment for patients with adenomyosis and heavy menstruation. Mirena offers highly effective contraception with the added benefits of reducing menstrual flow, correcting anemia, and relieving dysmenorrhea. However, for some patients with adenomyosis and a large uterine cavity, there is a risk of IUD migration and dislodgement, making the search for a relatively stable and effective intrauterine device imperative.

[0005] On July 28, 2024, a search was conducted in the China Patent Publication Database with "Mirena and Gini Ring" as the abstract keyword, and the option to allow synonym expansion was checked. Two documents were found: CN219847028U discloses a combined placement device of Gini Ring and Mirena Ring, which is not a combination of the two; CN217697037U discloses a treatment ring and a ring placement device, including: Mirena Ring, Mirena Ring includes a drug storage cylinder, a cross arm and The tail wire has two horizontal arms, each connected to one end of the drug storage tube. The two arms are arranged opposite each other and are elastically connected to the drug storage tube. The tail wire is connected to the other end of the drug storage tube. The Jinni ring includes a connecting wire and multiple copper sleeves, which are connected to the connecting wire in sequence along its length. One end of the connecting wire has a fixed knot, which is close to the two horizontal arms. The part of the connecting wire away from the fixed knot is wrapped around the outer wall of the drug storage tube, so that the multiple copper sleeves abut the outer wall of the drug storage tube. The Jinni ring can further limit the position of the Mirena ring in the uterine cavity, greatly reducing the possibility of the Mirena ring falling out.

[0006] It should be noted that the technology disclosed in CN217697037U requires the copper sleeve and the drug storage cylinder to be separate. When it comes to implants in the human body, the fewer components and the smaller the volume, the better. At the same time, this technology includes two support arms.

[0007] It is completely different from the conception of this patent. Utility Model Content

[0008] The purpose of the utility model is to provide a more effective comprehensive Giniman Yuele structure that can release drugs using copper rings. The specific purpose can be seen in the multiple substantial technical effects of the specific implementation part.

[0009] In order to achieve the above purpose, the present invention adopts the following technical solutions:

[0010] The integrated Giniman Yuele structure capable of releasing drugs using copper rings is characterized by:

[0011] The structure includes a fixing line 1, and the fixing line 1 can be nailed and hung in the uterine cavity;

[0012] The fixing wire 1 is provided with a plurality of copper rings 3, each of which comprises a hollow copper ring body 31;

[0013] An upper bracket 32 is arranged above the copper ring body 31, and a lower bracket 35 is arranged below the copper ring body 31;

[0014] The fixing line 1 passes through the through holes 33 on the upper bracket 32 and the lower bracket 35;

[0015] The lower support 35 can support the drug 34 arranged inside the copper ring 3, and the drug 34 is levonorgestrel.

[0016] A further technical solution of the present invention is that the original Mirena drug-releasing part is arranged at the bottom of the fixing line 1 .

[0017] A further technical solution of the present invention is that the upper bracket 32 and the lower bracket 35 are a cross bracket structure.

[0018] A further technical solution of the present invention is that the upper bracket 32 and the lower bracket 35 are mesh structures.

[0019] A further technical solution of the present invention is that the medicine 34 is in the form of a pellet.

[0020] A further technical solution of the present invention is that gaps exist between the multiple copper rings.

[0021] A further technical solution of the present invention is that the fixing line 1 is a nylon rope.

[0022] A further technical solution of the present invention is that a ring-shaped tail end 6 is arranged at the bottom of the original Mirena drug-releasing part.

[0023] The present invention, employing the above technical solution, has the following beneficial effects compared to the prior art: Compared to the closest comparative document CN217697037U, which discloses a therapeutic ring and ring placement device, this patent, unlike that technology, which "requires separate copper sleeves and drug storage cartridges," combines the copper sleeve and drug storage cartridge into one, creating a groundbreaking integration of the previously separate Mirena and Gini Ring devices, resulting in a superior technology. By combining the Mirena and Gini Ring into one device, the Gini knot secures the Mirena within the superficial myometrium of the uterus, effectively resolving the issue of Mirena's downward migration and dislodgement, providing a therapeutic benefit while also providing a highly effective and long-lasting contraceptive effect for women seeking contraception. The primary side effects of IUD placement are lower back pain and prolonged menstruation. This improved device reduces the incidence of lower back pain and prolonged menstruation associated with Gini Ring-fixed Mirena. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] In order to further illustrate the present invention, the following is a further description with reference to the accompanying drawings:

[0025] Figure 1 This is the structural diagram of the copper ring;

[0026] Figure 2 An improved diagram of the utility model as a whole;

[0027] Figure 3 A schematic diagram of the preparatory installation for the utility model;

[0028] Figure 4This is a further improved diagram of the utility model;

[0029] Figure 5 It is a structural diagram of the annular tail end of the bottom of the utility model;

[0030] Among them: 1. Fixing line; 2. Knot; 3. Copper ring; 31. Copper ring body; 32. Upper bracket; 33. Through hole; 34. Drug; 35. Lower bracket; 4. Drug; 5. Original Mirena drug release part; 6. Ring tail end; 7. Genie ring installation structure. DETAILED DESCRIPTION

[0031] The present invention is further explained below in conjunction with the accompanying drawings and specific embodiments. It should be understood that the following specific embodiments are only used to illustrate the present invention and are not used to limit the scope of the present invention. In the description of the present invention, it should be noted that the terms "center", "up", "down", "left", "right", "vertical", "horizontal", "inside", "outside", "top", "bottom" and the like indicate directions or positional relationships based on the directions or positional relationships shown in the accompanying drawings. They are only for the convenience of describing the present invention and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific direction, be constructed and operated in a specific direction. Therefore, they cannot be understood as limitations on the present invention. In addition, unless otherwise clearly specified and limited, the terms "installed", "connected" and "connected" should be understood in a broad sense. For example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection, or an indirect connection through an intermediate medium, or it can be a communication between the internal parts of two components. For ordinary technicians in this field, the specific meanings of the above terms in the present invention can be understood according to the specific circumstances.

[0032] It should be noted that, in this document, relational terms such as first and second, etc., are used only to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any actual relationship or order between these entities or operations. Moreover, the terms "comprises," "comprising," or any other variations thereof are intended to cover non-exclusive inclusion, such that a process, method, article, or apparatus that includes a list of elements includes not only those elements but also other elements not explicitly listed, or elements inherent to such process, method, article, or apparatus.

[0033] This patent provides multiple parallel solutions. The differences in descriptions are improvements or parallel solutions based on the basic solution. Each solution has its own unique characteristics. In addition, the technical features involved in the different embodiments of the utility model described below can be combined with each other as long as they do not conflict with each other. Fixing methods not described in this article can be any fixing method such as threaded fixing, bolt fixing, or gluing.

[0034] Example 1: Combined with all the drawings; a comprehensive Giniman Yuele structure capable of releasing drugs using a copper ring, characterized in that,

[0035] The structure includes a fixing line 1, and the fixing line 1 can be nailed and hung in the uterine cavity;

[0036] The fixing wire 1 is provided with a plurality of copper rings 3, each of which comprises a hollow copper ring body 31;

[0037] An upper bracket 32 is arranged above the copper ring body 31, and a lower bracket 35 is arranged below the copper ring body 31;

[0038] The fixing line 1 passes through the through holes 33 on the upper bracket 32 and the lower bracket 35;

[0039] The lower support 35 supports the drug 34, levonorgestrel, placed inside the copper ring 3. The substantial technical effects and implementation process of this technical solution, namely its basic functions, are as follows: Compared to the treatment ring and ring placement device disclosed in the closest reference CN217697037U, which "requires separate copper sleeves and drug storage cartridges," this patent's two-in-one copper sleeve and drug storage cartridge are innovatively combined, allowing the previously separate Mirena and Gini Ring to function as a two-in-one device, resulting in superior technology. By combining the Mirena and Gini Ring into one, the Gini knot secures the Mirena within the superficial myometrium using a Guinness knot, effectively resolving the issue of Mirena's downward migration and dislodgement, achieving a therapeutic effect while also providing effective and long-lasting contraception for women seeking contraception. The main side effects of IUD placement are lower back pain and prolonged menstruation. This improved device reduces the incidence of lower back pain and prolonged menstruation associated with Gini Ring fixation. The position where the fixing line 1 passes through the through hole is preferably fixed with a knot.

[0040] Example 2: As a further improved, parallel, or independent solution, the original Mirena drug release unit is located at the bottom of the fixing line 1. The essential technical effects and implementation process of this technical solution, i.e., its basic functions, are as follows: In addition to the basic solution of Example 1, a drug-adding structure can be added as an optional feature. The Guinness ring's knot is used to secure the Mirena to prevent downward movement and dislocation.

[0041] First, cut the Genesis Ring below the first metal segment at the top and remove the five lower segments, reducing the amount of metal in the uterus. Second, cut the cross arm of the Mirena Ring and tie it in an inverted position between the Genesis segment and the first metal segment. This reduces the chance of the secondary arm moving and irritating the endometrium, making Mirena placement easier. After the Ring expires, use forceps to pull the Mirena's tail thread downward from the external cervical os to easily remove the fixed Ring, without entering or exiting the uterine cavity. Therefore, both insertion and removal under color Doppler ultrasound guidance are safe and reliable.

[0042] 1 Reduce the risk of Mirena moving downward or falling off:

[0043] 2 Reduce the financial burden on patients:

[0044] The current clinical charge for Mirena is 1,153 yuan, and it is valid for 5 years. If it moves downward or falls off within a short period of time after placement, it will increase the financial burden on the patient.

[0045] 3. Reduce gynecological surgical trauma:

[0046] After securing Mirena with the Guinness Knot, the Guinness Knot can be used to secure Mirena securely to the fundus of the uterus, reducing the risk of downward migration or dislodgment, effectively alleviating dysmenorrhea and reducing menstrual flow. This reduces the surgical trauma associated with uterine myomectomy or even hysterectomy.

[0047] (4) Improve patient satisfaction:

[0048] After placement, Ingiman can provide effective contraception on the one hand, and effectively treat the symptoms of adenomyosis on the other hand, greatly improving patient compliance and satisfaction.

[0049] Embodiment 3: As a further improved solution, parallel solution, or optional independent solution, the upper bracket 32 and the lower bracket 35 are a cross bracket structure. This embodiment is a parallel embodiment of the fourth embodiment.

[0050] Embodiment 4: As a further improved solution or a parallel solution or an optional independent solution, the upper bracket 32 and the lower bracket 35 are mesh structures.

[0051] Example 5: As a further improved solution or a parallel solution or an optional independent solution, the drug 34 is in a fast-acting state.

[0052] Example 6: As a further improved solution or parallel solution or optional independent solution, there are gaps between the multiple copper rings. The substantial technical effect and implementation process of the technical solution herein, i.e., the basic function, are as follows: facilitating proper overall steering and adapting to the curves of the human body.

[0053] Example 7: As a further improved solution or parallel solution or optional independent solution, the fixing line 1 is a nylon rope. The substantial technical effect and implementation process of the technical solution here, i.e., the basic function, are as follows: Sterile nylon rope is preferred.

[0054] Example 8: As a further improved solution or parallel solution or optional independent solution, the bottom of the original Mirena drug release part is provided with a ring-shaped tail end 6. The substantial technical effect and implementation process of the technical solution herein, i.e., the basic function, are as follows: easy to pull out.

[0055] When the whole device is put in, it is installed by using the Jini ring installation structure 7, for example, the installation structure of the non-stent fixed intrauterine contraceptive device containing indomethacin silicone rubber produced by Tianjin Hejie Medical Instrument Co., Ltd. can be used.

[0056] Innovatively, each of the above effects exists independently, and a set of structures can be used to combine the above results.

[0057] It should be noted that the multiple solutions provided by this patent include the basic solutions themselves, are independent of each other, and do not restrict each other, but they can also be combined with each other without conflict to achieve multiple effects together.

[0058] The above shows and describes the basic principles, main features, and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited to the above embodiments. The above embodiments and descriptions are merely illustrative of the principles of the present invention. Various changes and improvements may be made to the present invention without departing from the spirit and scope of the present invention, and such changes and improvements fall within the scope of the claimed invention.

Claims

1. A comprehensive Giniman Yuele structure capable of releasing drugs using a copper ring, the structure comprising a fixing line (1) which can be nailed and hung in the uterine cavity; It is characterized by: The fixing line (1) is provided with a plurality of copper rings (3), each of which comprises a hollow copper ring body (31); An upper bracket (32) is arranged above the copper ring body (31), and a lower bracket (35) is arranged below the copper ring body (31); The fixing line (1) passes through the through holes (33) on the upper bracket (32) and the lower bracket (35); The lower support (35) can support the drug (34) arranged inside the copper ring (3), and the drug (34) is levonorgestrel.

2. The integrated Giniman structure capable of releasing drugs using a copper ring as claimed in claim 1, characterized in that: The original Mirena drug-releasing portion is arranged at the bottom of the fixing line (1).

3. The integrated Giniman structure capable of releasing drugs using a copper ring as claimed in claim 1, characterized in that: The upper bracket (32) and the lower bracket (35) are a cross bracket structure.

4. The integrated Giniman structure capable of releasing drugs using a copper ring as claimed in claim 1, characterized in that: The upper bracket (32) and the lower bracket (35) are mesh structures.

5. The integrated Giniman structure capable of releasing drugs using a copper ring as claimed in claim 1, characterized in that: The medicine (34) is in a quick-acting form.

6. The integrated Giniman structure capable of releasing drugs using a copper ring as claimed in claim 1, characterized in that: There are gaps between the multiple copper rings.

7. The integrated Giniman structure capable of releasing drugs using a copper ring as claimed in claim 1, characterized in that: The fixing line (1) is a nylon rope.

8. The integrated Giniman structure capable of releasing drugs using a copper ring as claimed in claim 2, characterized in that: The bottom of the original Mirena drug release part is provided with a ring-shaped tail end (6).

Images